Literature DB >> 23698059

Antiretroviral resource allocation for HIV prevention.

Jerome Amir Singh1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23698059     DOI： 10.1097/QAD.0b013e32835f2b30

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  7 in total

1.  Bioethical challenges with HIV treatment as prevention.

Authors:  Jeremy Sugarman
Journal:  Clin Infect Dis       Date:  2014-07       Impact factor: 9.079

2.  The impact of patient race on clinical decisions related to prescribing HIV pre-exposure prophylaxis (PrEP): assumptions about sexual risk compensation and implications for access.

Authors:  Sarah K Calabrese; Valerie A Earnshaw; Kristen Underhill; Nathan B Hansen; John F Dovidio
Journal:  AIDS Behav       Date:  2014-02

3.  Social justice and HIV vaccine research in the age of pre-exposure prophylaxis and treatment as prevention.

Authors:  Theodore C Bailey; Jeremy Sugarman
Journal:  Curr HIV Res       Date:  2013-09       Impact factor: 1.581

4.  Optimal Individualized Treatments in Resource-Limited Settings.

Authors:  Alexander R Luedtke; Mark J van der Laan
Journal:  Int J Biostat       Date:  2016-05-01       Impact factor: 0.968

5.  Balancing efficiency, equity and feasibility of HIV treatment in South Africa - development of programmatic guidance.

Authors:  Rob Baltussen; Evelinn Mikkelsen; Noor Tromp; Annekarin Hurtig; Jens Byskov; Oystein Olsen; Kristine Bærøe; Jan A Hontelez; Jerome Singh; Ole F Norheim
Journal:  Cost Eff Resour Alloc       Date:  2013-10-09

6.  A scoping study to identify opportunities to advance the ethical implementation and scale-up of HIV treatment as prevention: priorities for empirical research.

Authors:  Rod Knight; Will Small; Basia Pakula; Kimberly Thomson; Jean Shoveller
Journal:  BMC Med Ethics       Date:  2014-07-03       Impact factor: 2.652

7.  Employing human rights frameworks to realize access to an HIV cure.

Authors:  Benjamin Mason Meier; Adriane Gelpi; Matthew M Kavanagh; Lisa Forman; Joseph J Amon
Journal:  J Int AIDS Soc       Date:  2015-11-13       Impact factor: 5.396
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.